HAVCR2 and colorectal carcinoma: We observed an overall trend towards an increase in all five ICs in stage II CRC and a decrease in stage III, although these trends were not statistically significant (except for Tim-3 in terms of frequency, p = 0.011), probably due to the high inter-patient variability within the pTNM stages.